Clinical Trial Update: A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia as a Result of Cancer Treatment With Cisplatin, a Platinum-containing Chemotherapy Drug [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing epoetin alfa to placebo for persistent anemia resulting from cisplatin-based cancer therapy, assessing safety and effectiveness.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Neoplasms

Drugs mentioned

• EPOETIN ALFA (EPOETIN ALFA)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Anemia, Neoplasms | Phase 2 | Status: COMPLETED